Healthcare
Eli Lilly Owns Pharma Now
Eli Lilly: the current brand demand leader in pharma. Mounjaro, Zepbound, Donanemab, the $20 billion+ U.S. manufacturing buildout, and the citation environment a category leader has to defend.
Tag
Mounjaro — Tagged Articles
Healthcare
OZEMPIC OWNS THE CHATBOX
Ozempic, Wegovy, Mounjaro, Zepbound — the highest-velocity pharma category since 2024. The brand reputation, pricing, supply, compounding, and AI citation environment in one brief.
Healthcare
Novo Nordisk vs Eli Lilly: Who Owns the GLP-1 Answer
Novo Nordisk owns the diabetes GLP-1 answer. Eli Lilly owns the weight-loss answer. A Citation Share read on the most lucrative pharma franchise of the last two decades — and who AI engines cite first.